查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1702177

2025 年至 2033 年 COPD 和气喘设备市场报告（按产品（吸入器、雾化器）、适应症（气喘、COPD）、配销通路（零售药局、医院、线上药局）和地区划分）

COPD and Asthma Devices Market Report by Product (Inhalers, Nebulizers), Indication (Asthma, COPD), Distribution Channel (Retail Pharmacies, Hospitals, Online Pharmacies), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球 COPD 和气喘设备市场规模达 478 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 705 亿美元，2025-2033 年期间的成长率 (CAGR) 为 4.42%。市场成长主要得益于具有即时监控功能的智慧吸入器技术的不断进步、呼吸系统疾病的日益流行、对个人化治疗方案的重视程度的提高（以实现更准确的药物输送）以及由于医疗保健服务的改善而导致的新兴市场需求的不断增长。

慢性阻塞性肺病 (COPD) 是一种导致肺部气流受阻的发炎性疾病。其早期症状包括呼吸短促、喘息、胸闷、伴随或不伴随黏液的慢性咳嗽、常感冒和喉咙痛。另一方面，气喘（也称为支气管气喘）是一种影响肺部气道的呼吸系统疾病。其症状为呼吸短促、胸闷、睡眠困难、咳嗽或喘息。这些呼吸系统疾病可以透过各种有助于输送吸入药物的设备来治疗。 COPD 和气喘装置，也称为肺部药物输送装置，用于呼吸系统疾病的永久治疗或抢救疗法。因此，它们在全球范围内获得了巨大的吸引力。

COPD 与气喘设备市场趋势：

全球老年人口不断增长，极易患慢性呼吸系统疾病，这是对市场产生正面影响的关键因素之一。此外，由于吸烟率上升导致呼吸系统疾病发生率上升，也增加了慢性阻塞性肺病和气喘设备的销售量。除此之外，医疗保健支出的增加和医疗保健产业的持续自动化也促进了市场的成长。先进医疗解决方案的广泛采用为全球製造商提供了丰厚的成长机会。目前，医疗保健从业者和肺部疾病专家更喜欢药物和设备的组合，因为它们具有快速有效的效果。此外，化学工业的扩张导致环境污染污染程度和呼吸问题的加剧，进而推动了市场的发展。此外，便携式药物输送设备的引入正在推动市场成长。

本报告回答的关键问题

  • 2024 年全球 COPD 和气喘设备市场规模？ 2025 年至 2033 年期间全球 COPD 和气喘设备市场的预期成长率为何？
  • 推动全球 COPD 和气喘设备市场发展的关键因素有哪些？
  • COVID-19 对全球 COPD 和气喘设备市场有何影响？
  • 根据产品，全球 COPD 和气喘设备市场是如何分布的？
  • 根据适应症，全球 COPD 和气喘设备市场如何分布？
  • 根据配销通路，全球 COPD 和气喘设备市场分布如何？
  • 全球 COPD 和气喘设备市场的主要区域有哪些？
  • 全球 COPD 和气喘设备市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球 COPD 与气喘设备市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 吸入器
    • 关键部分
      • 药物粉状吸入器（DPI）
      • 定量吸入器（MDI）
      • 软雾吸入器
  • 雾化器
    • 关键部分
      • 压缩机雾化器
      • 超音波雾化器
      • 网状雾化器

第七章：市场区隔：依指标

  • 气喘
  • 慢性阻塞性肺病

第八章：市场区隔：按配销通路

  • 零售药局
  • 医院
  • 网路药局

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Adherium Limited
    • Aristopharma Ltd.
    • AstraZeneca PLC
    • Baxter International Inc.
    • Boehringer Ingelheim International GmbH
    • Cohero Health Inc.
    • Koninklijke Philips NV
    • Omron Corporation
    • Pari Respiratory Equipment Inc.
    • Recipharm AB
    • Verona Pharma plc
Product Code: SR112025A6126

The global COPD and asthma devices market size reached USD 47.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 70.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.42% during 2025-2033. The market growth is primarily driven by continual technological advancements in smart inhalers with real-time monitoring capabilities, growing prevalence of respiratory conditions, an enhanced emphasis on personalized treatment options for more accurate drug delivery and increasing demand in emerging markets due to improved healthcare access.

Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the lungs. Its early symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent cold, and throat soreness. On the other hand, asthma, also known as bronchial asthma, is a respiratory disorder that affects the airways in the lungs. Its symptoms are shortness of breath, chest tightness, trouble sleeping, and coughing or wheezing attacks. These respiratory diseases are treated using various devices that help deliver inhaled medication. COPD and asthma devices, also known as pulmonary drug delivery devices, are used as permanent treatment or rescue therapy for respiratory diseases. As a result, they are gaining immense traction across the globe.

COPD and Asthma Devices Market Trends:

The growing global geriatric population, which is highly susceptible to chronic respiratory disorders, represents one of the key factors positively influencing the market. In addition, rising occurrences of respiratory diseases caused due to the rising smoking of cigarettes are increasing the sales of COPD and asthma devices. Apart from this, the increasing expenditure on healthcare and continuous automation in the healthcare industry are contributing to the market growth. The widespread adoption of advanced medical solutions is offering lucrative growth opportunities to manufacturers across the globe. At present, healthcare practitioners and pulmonary diseases specialists are preferring a combination of a drug and a device on account of their fast and effective outcome. Furthermore, the expansion of chemical industries is resulting in the rising environmental pollution level and breathing problems, which, in turn, is driving the market. Additionally, the introduction of portable drug delivery devices is propelling the market growth.

Key Market Segmentation:

Breakup by Product:

  • Inhalers
  • Drug Powdered Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • Soft Mist Inhalers
  • Nebulizers
  • Compressor Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

Breakup by Indication:

  • Asthma
  • COPD

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospitals
  • Online Pharmacies

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Adherium Limited, Aristopharma Ltd., AstraZeneca PLC, Baxter International Inc., Boehringer Ingelheim International GmbH, Cohero Health Inc., Koninklijke Philips N.V., Omron Corporation, Pari Respiratory Equipment Inc., Recipharm AB and Verona Pharma plc.

Key Questions Answered in This Report

  • 1.What was the size of the global COPD and asthma devices market market in 2024?
  • 2.What is the expected growth rate of the global COPD and asthma devices market during 2025-2033?
  • 3.What are the key factors driving the global COPD and asthma devices market?
  • 4.What has been the impact of COVID-19 on the global COPD and asthma devices market?
  • 5.What is the breakup of the global COPD and asthma devices market based on the product?
  • 6.What is the breakup of the global COPD and asthma devices market based on the indication?
  • 7.What is the breakup of the global COPD and asthma devices market based on distribution channel?
  • 8.What are the key regions in the global COPD and asthma devices market?
  • 9.Who are the key players/companies in the global COPD and asthma devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global COPD and Asthma Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Inhalers
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Drug Powdered Inhalers (DPIs)
      • 6.1.2.2 Metered Dose Inhalers (MDIs)
      • 6.1.2.3 Soft Mist Inhalers
    • 6.1.3 Market Forecast
  • 6.2 Nebulizers
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Compressor Nebulizers
      • 6.2.2.2 Ultrasonic Nebulizers
      • 6.2.2.3 Mesh Nebulizers
    • 6.2.3 Market Forecast

7 Market Breakup by Indication

  • 7.1 Asthma
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 COPD
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Adherium Limited
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Aristopharma Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 AstraZeneca PLC
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Baxter International Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Boehringer Ingelheim International GmbH
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Cohero Health Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Koninklijke Philips N.V.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Omron Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pari Respiratory Equipment Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Recipharm AB
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Verona Pharma plc
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: COPD and Asthma Devices Market: Major Drivers and Challenges
  • Figure 2: Global: COPD and Asthma Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: COPD and Asthma Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: COPD and Asthma Devices Market: Breakup by Product (in %), 2024
  • Figure 5: Global: COPD and Asthma Devices Market: Breakup by Indication (in %), 2024
  • Figure 6: Global: COPD and Asthma Devices Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: COPD and Asthma Devices Market: Breakup by Region (in %), 2024
  • Figure 8: Global: COPD and Asthma Devices (Inhalers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: COPD and Asthma Devices (Inhalers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: COPD and Asthma Devices (Nebulizers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: COPD and Asthma Devices (Nebulizers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: COPD and Asthma Devices (Asthma) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: COPD and Asthma Devices (Asthma) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: COPD and Asthma Devices (COPD) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: COPD and Asthma Devices (COPD) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: COPD and Asthma Devices (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: COPD and Asthma Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: COPD and Asthma Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: COPD and Asthma Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: COPD and Asthma Devices (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: COPD and Asthma Devices (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: North America: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: North America: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: United States: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: United States: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Canada: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Canada: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Asia-Pacific: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Asia-Pacific: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: China: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: China: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Japan: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Japan: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: India: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: India: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: South Korea: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: South Korea: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Australia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Australia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Indonesia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Indonesia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Europe: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Europe: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Germany: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Germany: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: France: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: France: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: United Kingdom: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: United Kingdom: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Italy: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Italy: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Spain: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Spain: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Russia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Russia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Latin America: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Latin America: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Brazil: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Brazil: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Mexico: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Mexico: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Middle East and Africa: COPD and Asthma Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Middle East and Africa: COPD and Asthma Devices Market: Breakup by Country (in %), 2024
  • Figure 70: Middle East and Africa: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Global: COPD and Asthma Devices Industry: SWOT Analysis
  • Figure 72: Global: COPD and Asthma Devices Industry: Value Chain Analysis
  • Figure 73: Global: COPD and Asthma Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: COPD and Asthma Devices Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: COPD and Asthma Devices Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: COPD and Asthma Devices Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 4: Global: COPD and Asthma Devices Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: COPD and Asthma Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: COPD and Asthma Devices Market: Competitive Structure
  • Table 7: Global: COPD and Asthma Devices Market: Key Players